For the first time, scientists have shown that heart muscle cells can regrow after a heart attack in humans, a process that ...
Background Both Takotsubo syndrome (TS) and ST-elevation myocardial infarction (STEMI) are conditions characterised by the ...
A major analysis led by the Centro Nacional de Investigaciones Cardiovasculares (CNIC), in collaboration with international institutions, has pooled data from 17,801 myocardial infarction survivors ...
Findings from the Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock (CERAMICS) registry ...
Patients with weak heart function who receive stem cell therapy shortly after a heart attack are at lower risk of developing heart failure and related hospital stays compared with standard care, finds ...
It has come to light that there are irregularities in a clinical trial published by The BMJ on 29 October 2025: Prevention of acute myocardial infarction induced heart failure by intracoronary ...
Scientists have developed a breakthrough injectable biomaterial that travels through the bloodstream to repair damaged tissue ...
Dennis T. Ko, M.D. However, a significant proportion of STEMI patients will "fail" to reperfuse following fibrinolytic therapy; indeed, normal coronary blood flow (TIMI flow grade 3) is achieved in ...
Cloud-Clone leverages its expertise in biological reagents, animal models, and primary cells to support global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results